Polyphor AG Registered Shares


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Polyphor AG is a clinical stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III develop-ment against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization.

Contact Information

Website: www.polyphor.com
Main Phone: +41 615671600
Address: Hegenheimermattweg 125
City / Town: Allschwil
Country: CH
Postal Code: CH-4123

Issuer Information

Exchange: OTO

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A